Porvair plc (LON:PRV – Get Free Report) insider James Mills sold 37,000 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of GBX 810, for a total transaction of £299,700.
Porvair Price Performance
Shares of Porvair stock opened at GBX 800 on Friday. Porvair plc has a 12 month low of GBX 624.70 and a 12 month high of GBX 920. The company has a current ratio of 1.83, a quick ratio of 1.22 and a debt-to-equity ratio of 19.67. The business’s 50-day moving average price is GBX 848.66 and its 200-day moving average price is GBX 788.75. The firm has a market capitalization of £369.09 million, a PE ratio of 21.80 and a beta of 0.76.
Porvair (LON:PRV – Get Free Report) last announced its quarterly earnings data on Monday, February 9th. The company reported GBX 42.30 earnings per share (EPS) for the quarter. Porvair had a net margin of 8.57% and a return on equity of 10.75%. Sell-side analysts forecast that Porvair plc will post 39.0358613 EPS for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on PRV
Porvair Company Profile
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
Featured Articles
- Five stocks we like better than Porvair
- 1,500 Banks Just Handed the Fed Your Bank Account
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Buy this stock tomorrow?
- Elon Musk already made me a “wealthy man”
- Sell this, buy that
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.
